Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Mitchell Lloyd Segal


  • Director at Valeant Pharmaceuticals International Inc. (VRX), 2013-06-18
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VRX $85.45 140 Director 21,174 2013-06-14 Filing
VRX $83.50 2,500 Director 21,034 2013-06-12 Filing
VRX $86.73 300 Director 18,534 2013-06-11 Filing
VRX $86.45 200 Director 630 2013-06-11 Filing
VRX $86.48 90 Director 430 2013-06-11 Filing